Thanks to advances in stem cell science, we can preserve an infant’s stem cells at birth and store them safely for his or her future.
Miami (PRWEB) May 31, 2014
Global Stem Cells Group and the Servet CordónVida Stem Cell Bank Clinic of Chile will be teaming up to organize the First International Symposium on Stem Cells and Regenerative Medicine in Santiago, Chile Sept. 26, 27 and 28. The three-day symposium will be followed by an intensive hands-on training course at the Servet Clinic for medical practitioners interested in learning techniques for harvesting stem cells for in-office medical therapies.
Symposium organizers plan to initiate a dialogue between researchers and practitioners to bridge the gap between “bench” science—research science that is exclusively conducted in a lab setting—and stem cell therapies delivered in the physician’s office.
The first-of-its-kind conference will host some of the world’s leading experts on stem cell research and therapies. Servet CordónVida General Manager Mauricio Cortes, Ph.D. says that Santiago is the perfect launching pad for the event, as awareness and increasing demand for stem cell services has swept the South American country’s healthcare market over the past decade.
“The use of human stem cells in medical therapies has attracted major scientific and public attention because stem cells are pluripotent, meaning they have the ability to differentiate into all body tissues,” Cortes says. “Knowing this, the possibilities for regenerating damaged or diseased tissue where no effective treatments existed before opens a new world of possibilities to patients and healthcare providers.
“We’re very excited to participate in this important conference.”
Servet CordónVida is a private umbilical cord blood bank that harvests and stores the hematopoietic-rich blood stem cells found in all newborns’ umbilical cords after birth. The hematopoietic tissue is responsible for the renewal of all components of the blood (hematopoiesis) and has the ability to regenerate bone marrow and restore depressed immune systems.
Umbilical (UCB) stem cells offer a wealth of therapeutic potential because they are up to 10 times more concentrated than bone marrow stem cells. In addition, UCB cells have a generous proliferative capacity with therapeutic potential that is very similar to embryonic stem cells, without the ethical debate associated with embryonic stem cell research and use.
Perhaps most significant is the fact that UCB cells are the purest adult stem cells available, coming from newborns who have not been exposed to disease or external damage. Many parents today are utilizing cord banks like Servet CordónVida to store their newborn’s UCB cells safely for future medicinal use if the need arises.
“Thanks to advances in stem cell science, we can preserve an infant’s stem cells at birth and store them safely for his or her future,” says CordónVida Director Javier Sáez. “Hopefully, this symposium will be the first of many like it in the future of regenerative medicine, because the more we discuss what we know about the power of stem cells to heal, the closer we get to sparing our patients from needless suffering when the cure is right before us.”
Global Stem Cells Group and Servet CordónVida represent a growing global community of committed stem cell researchers, practitioners and investors whose enthusiasm is a direct result of the hundreds of diseases and injuries that stem cell therapies are curing every day, and the list keeps growing. Global Stem Cell Group’s First International Symposium on Stem Cell Research and Regenerative Medicine will host experts from the U.S., Mexico, Greece, Hong Kong and other regions around the globe who will speak on the future of regenerative medicine and share experiences in their field of specialty. The Global Stem Cells Group Symposium is seeking to open lines of communication and cooperation, explore new and exciting techniques in stem cell therapy, and create an environment of education and learning.
The symposium will be held at the Santiago InterContinental Hotel. For more information on the symposium and the lineup of guests and speakers already confirmed, visit the First International Stem Cells and Regenerative Medicine website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.
To learn more about Global Stem Cells Group, visit http://www.stemcellsgroup.com, email bnovas(at)stemcellsgroup(dot)com, or call 305.224.1858.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Servet CordónVida Bank Stem Cell Clinic:
Servet CordónVida General Manager Mauricio Cortes, PhD, Director Javier Sáez and the team of team of highly skilled and committed practitioners are dedicated to sharing the known benefits and potential benefits of stem cell medicine with parents and patients both in Chile and abroad.
Servet CordónVida offers cutting edge technology in cryopreservation and storage of stem cells on behalf of parents and patients who understand the benefits of having their own stem cells available to meet possible future medical needs.